Sun Pharma Q2 Results: PAT beats estimates, rises 6% YoY to Rs 2,385 cr; revenue up 11%

Sun Pharmaceutical Industries on Wednesday reported a 6% year-on-year (YoY) growth in consolidated net profit for the September quarter to Rs 2,385 crore. Revenue from operations increased 11.3% YoY to Rs 12,192 crore. Operating profit, calculated as earnings before interest, taxes, depreciation, and amortization (EBITDA), for the quarter, rose nearly 8% on year to Rs 3,179.30 crore, but operating margin contracted by 91 basis points to 26.08%.

► Subscribe to The Economic Times for the latest video updates. It's free! - https://www.youtube.com/TheEconomicTi...

► More Videos @ ETTV - https://economictimes.indiatimes.com/TV

► https://EconomicTimes.com

► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/Economi...

Follow ET on:

► Facebook -   / economictimes  
► Twitter -   / economictimes  
► LinkedIn -   / economictimes  
► Instagram -   / the_economic_times  
► Flipboard - https://flipboard.com/@economictimes

#news #latestnews #economictimes #ET #TheEconomicTimes #businessnews